logo

For the Inventor, By the Inventor

Clapiers, France

Kathleen Biziere

This inventor holds 17 USPTO granted patents, primarily in Cholinergic System Compounds. Top assignees: Sanofi, Sanofi Sa, Societe Anonyme Sanofi. Active years: 1985-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathleen Biziere. Retrieved from https://idiyas.com/inventor/kathleen-biziere

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 162(Granted Patents)


Location History:

  • Clapiers, FR (1985 - 1990)
  • Riedisheim, FR (1993 - 1995)

Company Filing History:

goldMedal14 out of 1,562 
 
Sanofi
 patents
silverMedal1 out of 44 
 
Sanofi Sa
 patents
bronzeMedal1 out of 8 
 
Societe Anonyme Sanofi
 patents
4. 1 out of 1 
 
Societe Anonyme Styled: Sanofi
 patent

Years Active: 1985-1995

Loading Chart...
Areas of Expertise:
Cholinergic Receptors
Pyridazine Derivatives
Tricyclic Derivatives
Psychotropic Action
Central Nervous System
Nitrogen-Containing Heterocycles
Piperazine Compounds
Antidepressants
Medicaments
Pharmaceutical Compositions
Aminated Derivatives
4-Phenyl Quinazoline
17 patents (USPTO):Explore Patents
1. 5378706 - Fused-thiazole derivatives active on the cholinergic system, and (1995-01-03),
2. 5232921 - Thiazole derivatives active on the cholinergic system, process for (1993-08-03),
3. 4977152 - Novel tricyclic derivatives which are agonists of cholinergic receptors, (1990-12-11),
4. 4721711 - Pyridazine derivatives active on the central nervous system, and (1988-01-26),
5. 4677106 - Derivatives of 4-methyl 6-phenyl pyridazine, active on the central (1987-06-30),
6. 4631280 - Pyridazine derivatives having a psychotropic action, and medicaments in (1986-12-23),
7. 4624952 - Pyridazine and pyrimidine compounds active on the central nervous system (1986-11-25),
8. 4613603 - Compounds with a nitrogen-containing heterocyclic nucleus, and drugs in (1986-09-23),
9. 4604383 - Pyrrolidin-2-ones and medicaments containing them (1986-08-05),
10. 4576946 - Derivatives of 4-methyl 6-phenyl pyridazine active on the central (1986-03-18),
11. 4565814 - Pyridazine derivatives having a psychotropic action and compositions (1986-01-21),
12. 4542136 - 2-(1-Piperazinyl) pyrimidines, their salts and pharmaceutical (1985-09-17),
13. 4540696 - 1-Piperazinyl 4-phenylquinazoline compounds having antidepressant (1985-09-10),
14. 4524070 - Aminated derivatives of pyridazine substituted in 6 position by a (1985-06-18),
15. 4514397 - Derivatives of 4-methyl 6-phenyl pyridazine active on the central (1985-04-30),

Title: Innovations of Kathleen Biziere

Introduction

Kathleen Biziere is a prominent inventor based in Clapiers, France. She has made significant contributions to the field of chemistry, particularly in the development of thiazole derivatives. With a total of 17 patents to her name, her work has had a notable impact on the cholinergic system.

Latest Patents

Her latest patents include innovative thiazole derivatives that are active on the cholinergic system. These inventions correspond to a general formula where R1 and R2 can represent various groups, including hydrogen, alkyl groups, and phenyl groups, among others. The complexity of these compounds showcases her expertise in medicinal chemistry and their potential applications in pharmaceuticals.

Career Highlights

Throughout her career, Kathleen has worked with notable companies such as Sanofi and Société Anonyme Sanofi. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Some of her coworkers include Andre Hallot and Camille G. Wermuth, with whom she has collaborated on various projects. Their combined expertise has further advanced the research and development of innovative chemical compounds.

Conclusion

Kathleen Biziere's contributions to the field of chemistry through her patents and collaborations highlight her as a significant figure in the world of innovation. Her work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…